Science & Enterprise subscription

Follow us on Twitter

  • New post on Science and Enterprise: Editorial Posts Resume Tomorrow https://t.co/ZTVMsYlwg8 #Science #Business
    about 6 hours ago
  • As mobile phones, smart watches, and tablets play an increasingly key role in our daily lives, a new report shows m… https://t.co/HNOl3qa4oI
    about 2 days ago
  • New post on Science and Enterprise: Infographic – Mobile Industry’s Economic Role https://t.co/aMBZtn0gkM #Science #Business
    about 2 days ago
  • FDA expert panel gives thumbs-up to Aimmune’s peanut allergy drug https://t.co/srCucGLuB5
    about 3 days ago
  • A developer of a drug for migraine formulated as a dry powder and given as a nasal spray is raising $82.5 million i… https://t.co/gn4NSNTmBR
    about 3 days ago

Please share Science & Enterprise

Companies Call for Genome Editing Regulations

Crispr genome edits illustration

A group of companies developing treatments for disease using genome editing are calling for regulations and standards to govern these technologies in regenerative medicine. . . . → Read More: Companies Call for Genome Editing Regulations

Patch Designed for Vaccines, Cancer Treatments

Microneedle patch

An engineering team designed a small skin patch with tiny needles that in lab mice quickly delivers vaccines and possibly treatments for melanoma. . . . → Read More: Patch Designed for Vaccines, Cancer Treatments

Crispr Deployed for Programmable Smart Hydrogels

Crispr hydrogel

Bio-engineers developed a process using the gene editing technique Crispr to design gel materials with properties added for drug delivery, diagnostics, and electronic circuits. . . . → Read More: Crispr Deployed for Programmable Smart Hydrogels

Small Biz Grant Funds Pre-Term Gut Microbe Therapy

Microbiome graphic

National Institutes of Health is supporting development of an extended-release probiotic treatment for necrotizing enterocolitis, an intestinal disease affecting premature infants. . . . → Read More: Small Biz Grant Funds Pre-Term Gut Microbe Therapy

Carb-X Funds Drug-Resistant Bacterial Vaccine

Klebsiella pneumoniae

A company developing vaccines with synthetic biology is receiving a grant for a vaccine to prevent infections from drug-resistant Klebsiella pneumoniae bacteria. . . . → Read More: Carb-X Funds Drug-Resistant Bacterial Vaccine

FDA Okays Celiac Disease Engineered Microbe Trial

fresh bread

A company making synthetic biological therapies received authorization to begin clinical trials in the U.S. for an engineered microbe to treat celiac disease. . . . → Read More: FDA Okays Celiac Disease Engineered Microbe Trial

Aging Therapy Network Adds $100M to Venture Round

Hands on lap

An enterprise supporting a group of companies developing new drugs to address the aging process raised another $100 million in its second venture funding round. . . . → Read More: Aging Therapy Network Adds $100M to Venture Round

Controlled Brain Tumor Gene Therapy Shown Safe

Brain tumor graphic

A clinical trial shows an experimental gene therapy that controls release of a powerful anti-tumor protein is safe for patients with stubborn glioblastoma, a type of brain cancer. . . . → Read More: Controlled Brain Tumor Gene Therapy Shown Safe

Trial Shows Two Drugs Can Treat Ebola Virus

Ebola virus

A clinical trial in the Congo shows two different therapies made with synthetic antibodies are better able to treat Ebola infections than two other drugs tested. . . . → Read More: Trial Shows Two Drugs Can Treat Ebola Virus

Engineered Bacteria Hydrogels Designed for Gut Repair

Nanofibers from engineered E. coli

Biomedical engineers genetically altered bacteria that when added to gel materials can be applied like a spray or ointment to help heal intestinal surfaces. . . . → Read More: Engineered Bacteria Hydrogels Designed for Gut Repair